Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease

Mao Shin Lin, Hung Yuan Li, Jung Nan Wei, Cheng Hsin Lin, David J. Smith, Jani Vainio, Shyang Rong Shih, Ying Hui Chen, Lung Chun Lin, Hsien Li Kao, Lee Ming Chuang, Ming Fong Chen

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objectives: An increased level of serum vascular adhesion protein-1 (VAP-1) has been found in patients with diabetes mellitus and vascular disorders. This study examined whether serum VAP-1 levels are associated with chronic kidney disease (CKD). Design and methods: We included 262 subjects aged 30 and above with fasting plasma glucose level <7 mmol/L checked within 1 year. First morning urine specimens were collected. Microalbuminuria was defined if urinary albumin-to-creatinine ratio ≥ 30 μg/mg creatinine. The glomerular filtration rate (GFR) was estimated. CKD stages were defined according to the suggestions of the National Kidney Foundation. Serum VAP-1 levels were analyzed by immunofluorometric assay. Results: Serum VAP-1 levels were positively associated with the urinary albumin-to-creatinine ratio ( r = 0.29, p <0.0001) and negatively associated with estimated GFR (r = -0.24, p = 0.0001). Subjects with CKD stage 2 (N = 51) and stage 3 (N = 91) had significantly higher levels of serum VAP-1 than those without CKD (p = 0.0003 and p = 0.035, adjusted for age and gender, respectively). A high serum VAP-1 level was associated with the presence of CKD (OR 1.63 for 1 SD increase of VAP-1, p = 0.018), adjusting for age, sex, and smoking. Ordered logit models revealed that high serum VAP-1 levels correlated with advanced stages of CKD. Conclusions: Serum levels of VAP-1 are associated with the severity of kidney damage or stages of kidney disease. The true mechanism which links the serum VAP-1 and CKD remains to be elucidated in further studies.

Original languageEnglish
Pages (from-to)1362-1367
Number of pages6
JournalClinical Biochemistry
Volume41
Issue number16-17
DOIs
Publication statusPublished - Nov 2008
Externally publishedYes

Fingerprint

Chronic Renal Insufficiency
Blood Vessels
Adhesion
Serum
Proteins
Creatinine
Glomerular Filtration Rate
Albumins
Fluoroimmunoassay
Kidney
Medical problems
Kidney Diseases
Assays
Fasting
Diabetes Mellitus
Logistic Models
Smoking
Plasmas
Urine
Glucose

Keywords

  • Amine oxidase
  • Chronic kidney disease
  • Microalbuminuria
  • SSAO
  • Vascular adhesion protein-1

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. / Lin, Mao Shin; Li, Hung Yuan; Wei, Jung Nan; Lin, Cheng Hsin; Smith, David J.; Vainio, Jani; Shih, Shyang Rong; Chen, Ying Hui; Lin, Lung Chun; Kao, Hsien Li; Chuang, Lee Ming; Chen, Ming Fong.

In: Clinical Biochemistry, Vol. 41, No. 16-17, 11.2008, p. 1362-1367.

Research output: Contribution to journalArticle

Lin, MS, Li, HY, Wei, JN, Lin, CH, Smith, DJ, Vainio, J, Shih, SR, Chen, YH, Lin, LC, Kao, HL, Chuang, LM & Chen, MF 2008, 'Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease', Clinical Biochemistry, vol. 41, no. 16-17, pp. 1362-1367. https://doi.org/10.1016/j.clinbiochem.2008.06.019
Lin, Mao Shin ; Li, Hung Yuan ; Wei, Jung Nan ; Lin, Cheng Hsin ; Smith, David J. ; Vainio, Jani ; Shih, Shyang Rong ; Chen, Ying Hui ; Lin, Lung Chun ; Kao, Hsien Li ; Chuang, Lee Ming ; Chen, Ming Fong. / Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. In: Clinical Biochemistry. 2008 ; Vol. 41, No. 16-17. pp. 1362-1367.
@article{9e80dada0f0f404f94466889eff7dc5e,
title = "Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease",
abstract = "Objectives: An increased level of serum vascular adhesion protein-1 (VAP-1) has been found in patients with diabetes mellitus and vascular disorders. This study examined whether serum VAP-1 levels are associated with chronic kidney disease (CKD). Design and methods: We included 262 subjects aged 30 and above with fasting plasma glucose level <7 mmol/L checked within 1 year. First morning urine specimens were collected. Microalbuminuria was defined if urinary albumin-to-creatinine ratio ≥ 30 μg/mg creatinine. The glomerular filtration rate (GFR) was estimated. CKD stages were defined according to the suggestions of the National Kidney Foundation. Serum VAP-1 levels were analyzed by immunofluorometric assay. Results: Serum VAP-1 levels were positively associated with the urinary albumin-to-creatinine ratio ( r = 0.29, p <0.0001) and negatively associated with estimated GFR (r = -0.24, p = 0.0001). Subjects with CKD stage 2 (N = 51) and stage 3 (N = 91) had significantly higher levels of serum VAP-1 than those without CKD (p = 0.0003 and p = 0.035, adjusted for age and gender, respectively). A high serum VAP-1 level was associated with the presence of CKD (OR 1.63 for 1 SD increase of VAP-1, p = 0.018), adjusting for age, sex, and smoking. Ordered logit models revealed that high serum VAP-1 levels correlated with advanced stages of CKD. Conclusions: Serum levels of VAP-1 are associated with the severity of kidney damage or stages of kidney disease. The true mechanism which links the serum VAP-1 and CKD remains to be elucidated in further studies.",
keywords = "Amine oxidase, Chronic kidney disease, Microalbuminuria, SSAO, Vascular adhesion protein-1",
author = "Lin, {Mao Shin} and Li, {Hung Yuan} and Wei, {Jung Nan} and Lin, {Cheng Hsin} and Smith, {David J.} and Jani Vainio and Shih, {Shyang Rong} and Chen, {Ying Hui} and Lin, {Lung Chun} and Kao, {Hsien Li} and Chuang, {Lee Ming} and Chen, {Ming Fong}",
year = "2008",
month = "11",
doi = "10.1016/j.clinbiochem.2008.06.019",
language = "English",
volume = "41",
pages = "1362--1367",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "16-17",

}

TY - JOUR

T1 - Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease

AU - Lin, Mao Shin

AU - Li, Hung Yuan

AU - Wei, Jung Nan

AU - Lin, Cheng Hsin

AU - Smith, David J.

AU - Vainio, Jani

AU - Shih, Shyang Rong

AU - Chen, Ying Hui

AU - Lin, Lung Chun

AU - Kao, Hsien Li

AU - Chuang, Lee Ming

AU - Chen, Ming Fong

PY - 2008/11

Y1 - 2008/11

N2 - Objectives: An increased level of serum vascular adhesion protein-1 (VAP-1) has been found in patients with diabetes mellitus and vascular disorders. This study examined whether serum VAP-1 levels are associated with chronic kidney disease (CKD). Design and methods: We included 262 subjects aged 30 and above with fasting plasma glucose level <7 mmol/L checked within 1 year. First morning urine specimens were collected. Microalbuminuria was defined if urinary albumin-to-creatinine ratio ≥ 30 μg/mg creatinine. The glomerular filtration rate (GFR) was estimated. CKD stages were defined according to the suggestions of the National Kidney Foundation. Serum VAP-1 levels were analyzed by immunofluorometric assay. Results: Serum VAP-1 levels were positively associated with the urinary albumin-to-creatinine ratio ( r = 0.29, p <0.0001) and negatively associated with estimated GFR (r = -0.24, p = 0.0001). Subjects with CKD stage 2 (N = 51) and stage 3 (N = 91) had significantly higher levels of serum VAP-1 than those without CKD (p = 0.0003 and p = 0.035, adjusted for age and gender, respectively). A high serum VAP-1 level was associated with the presence of CKD (OR 1.63 for 1 SD increase of VAP-1, p = 0.018), adjusting for age, sex, and smoking. Ordered logit models revealed that high serum VAP-1 levels correlated with advanced stages of CKD. Conclusions: Serum levels of VAP-1 are associated with the severity of kidney damage or stages of kidney disease. The true mechanism which links the serum VAP-1 and CKD remains to be elucidated in further studies.

AB - Objectives: An increased level of serum vascular adhesion protein-1 (VAP-1) has been found in patients with diabetes mellitus and vascular disorders. This study examined whether serum VAP-1 levels are associated with chronic kidney disease (CKD). Design and methods: We included 262 subjects aged 30 and above with fasting plasma glucose level <7 mmol/L checked within 1 year. First morning urine specimens were collected. Microalbuminuria was defined if urinary albumin-to-creatinine ratio ≥ 30 μg/mg creatinine. The glomerular filtration rate (GFR) was estimated. CKD stages were defined according to the suggestions of the National Kidney Foundation. Serum VAP-1 levels were analyzed by immunofluorometric assay. Results: Serum VAP-1 levels were positively associated with the urinary albumin-to-creatinine ratio ( r = 0.29, p <0.0001) and negatively associated with estimated GFR (r = -0.24, p = 0.0001). Subjects with CKD stage 2 (N = 51) and stage 3 (N = 91) had significantly higher levels of serum VAP-1 than those without CKD (p = 0.0003 and p = 0.035, adjusted for age and gender, respectively). A high serum VAP-1 level was associated with the presence of CKD (OR 1.63 for 1 SD increase of VAP-1, p = 0.018), adjusting for age, sex, and smoking. Ordered logit models revealed that high serum VAP-1 levels correlated with advanced stages of CKD. Conclusions: Serum levels of VAP-1 are associated with the severity of kidney damage or stages of kidney disease. The true mechanism which links the serum VAP-1 and CKD remains to be elucidated in further studies.

KW - Amine oxidase

KW - Chronic kidney disease

KW - Microalbuminuria

KW - SSAO

KW - Vascular adhesion protein-1

UR - http://www.scopus.com/inward/record.url?scp=55049096363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55049096363&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2008.06.019

DO - 10.1016/j.clinbiochem.2008.06.019

M3 - Article

C2 - 18644360

AN - SCOPUS:55049096363

VL - 41

SP - 1362

EP - 1367

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 16-17

ER -